Cargando…

Estimating the infection burden of COVID-19 in Malaysia

Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaraj, Vivek Jason, Ng, Chiu-Wan, Bulgiba, Awang, Appannan, Maheshwara Rao, Rampal, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642899/
https://www.ncbi.nlm.nih.gov/pubmed/36346816
http://dx.doi.org/10.1371/journal.pntd.0010887
_version_ 1784826410474405888
author Jayaraj, Vivek Jason
Ng, Chiu-Wan
Bulgiba, Awang
Appannan, Maheshwara Rao
Rampal, Sanjay
author_facet Jayaraj, Vivek Jason
Ng, Chiu-Wan
Bulgiba, Awang
Appannan, Maheshwara Rao
Rampal, Sanjay
author_sort Jayaraj, Vivek Jason
collection PubMed
description Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported cases and mortalities were collated from the Ministry of Health official GitHub between 1 March 2020 and 30 December 2021. We estimated the total and age-stratified monthly incidence rates, mortality rates, and aCFR. Estimated new infections were inferred from the age-stratified aCFR. The total estimated infections between 1 March 2020 and 30 December 2021 was 9,955,000-cases (95% CI: 6,626,000–18,985,000). The proportion of COVID-19 infections in ages 0–11, 12–17, 18–50, 51–65, and above 65 years were 19.9% (n = 1,982,000), 2.4% (n = 236,000), 66.1% (n = 6,577,000), 9.1% (n = 901,000), 2.6% (n = 256,000), respectively. Approximately 32.8% of the total population in Malaysia was estimated to have been infected with COVID-19 by the end of December 2021. These estimations highlight a more accurate infection burden in Malaysia. It provides the first national-level prevalence estimates in Malaysia that adjusted for underdiagnosis. Naturally acquired community immunity has increased, but approximately 68.1% of the population remains susceptible. Population estimates of the infection burden are critical to determine the need for booster doses and calibration of public health measures.
format Online
Article
Text
id pubmed-9642899
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-96428992022-11-15 Estimating the infection burden of COVID-19 in Malaysia Jayaraj, Vivek Jason Ng, Chiu-Wan Bulgiba, Awang Appannan, Maheshwara Rao Rampal, Sanjay PLoS Negl Trop Dis Research Article Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported cases and mortalities were collated from the Ministry of Health official GitHub between 1 March 2020 and 30 December 2021. We estimated the total and age-stratified monthly incidence rates, mortality rates, and aCFR. Estimated new infections were inferred from the age-stratified aCFR. The total estimated infections between 1 March 2020 and 30 December 2021 was 9,955,000-cases (95% CI: 6,626,000–18,985,000). The proportion of COVID-19 infections in ages 0–11, 12–17, 18–50, 51–65, and above 65 years were 19.9% (n = 1,982,000), 2.4% (n = 236,000), 66.1% (n = 6,577,000), 9.1% (n = 901,000), 2.6% (n = 256,000), respectively. Approximately 32.8% of the total population in Malaysia was estimated to have been infected with COVID-19 by the end of December 2021. These estimations highlight a more accurate infection burden in Malaysia. It provides the first national-level prevalence estimates in Malaysia that adjusted for underdiagnosis. Naturally acquired community immunity has increased, but approximately 68.1% of the population remains susceptible. Population estimates of the infection burden are critical to determine the need for booster doses and calibration of public health measures. Public Library of Science 2022-11-08 /pmc/articles/PMC9642899/ /pubmed/36346816 http://dx.doi.org/10.1371/journal.pntd.0010887 Text en © 2022 Jayaraj et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Jayaraj, Vivek Jason
Ng, Chiu-Wan
Bulgiba, Awang
Appannan, Maheshwara Rao
Rampal, Sanjay
Estimating the infection burden of COVID-19 in Malaysia
title Estimating the infection burden of COVID-19 in Malaysia
title_full Estimating the infection burden of COVID-19 in Malaysia
title_fullStr Estimating the infection burden of COVID-19 in Malaysia
title_full_unstemmed Estimating the infection burden of COVID-19 in Malaysia
title_short Estimating the infection burden of COVID-19 in Malaysia
title_sort estimating the infection burden of covid-19 in malaysia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642899/
https://www.ncbi.nlm.nih.gov/pubmed/36346816
http://dx.doi.org/10.1371/journal.pntd.0010887
work_keys_str_mv AT jayarajvivekjason estimatingtheinfectionburdenofcovid19inmalaysia
AT ngchiuwan estimatingtheinfectionburdenofcovid19inmalaysia
AT bulgibaawang estimatingtheinfectionburdenofcovid19inmalaysia
AT appannanmaheshwararao estimatingtheinfectionburdenofcovid19inmalaysia
AT rampalsanjay estimatingtheinfectionburdenofcovid19inmalaysia